Concepedia

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

Brandon Essink, Laurence Chu, William Seger, Elizabeth Barranco, Nancy Le Cam, Hamilton Bennett, Veronica Faughnan, Rolando Pajón, Yamuna Devi Paila, Brooke Bollman,

The Lancet Infectious Diseases · 2023 · 141 citations · 15 references

DOI

Concepts

References

15

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine · 2020 · 10.7K citations · Full text

, , +17

Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007

Robert S. Lanciotti, Olga Kosoy, Janeen Laven et al. · Emerging infectious diseases · 2008 · 2.2K citations · Full text

, , +17

Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus

Moritz U. G. Kraemer, Robert C. Reiner, Oliver J. Brady et al. · Nature Microbiology · 2019 · 1.5K citations · Full text

, , +17

Modified mRNA Vaccines Protect against Zika Virus Infection

Justin M. Richner, Sunny Himansu, Kimberly A. Dowd et al. · Cell · 2017 · 898 citations · Full text

, , +14

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · New England Journal of Medicine · 2021 · 658 citations · Full text

, , +17